Published in
Elsevier, Journal of Cancer Policy, (13), p. 11-17
DOI: 10.1016/j.jcpo.2017.05.001
Links
Tools
Cost minimization analysis of Herceptin subcutaneous versus Herceptin intravenous treatment for patients with HER2+ Breast cancer in Greece
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 